Skip to content

Clinical trials

Phase 2 Hepatitis B trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hepatitis B Phase: Phase 2 Country / region: South Korea Clear all

26 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20032
20101
20141
20154
20162
20172
20181
20191
20203
20215
20241
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed13
Terminated8
Active, not recruiting3
Recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
GlaxoSmithKline6
Arrowhead Pharmaceuticals4
Bukwang Pharmaceutical3
Green Cross Corporation2
Vir Biotechnology, Inc.2
Aligos Therapeutics1
Arbutus Biopharma Corporation1
Assembly Biosciences1
AusperBio Therapeutics Inc.1
Brii Biosciences Limited1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hepatitis B26
Hepatitis B, Chronic13
Hepatitis7
Hepatitis, Chronic2
Blood-Borne Infections1
Bronchiolitis Obliterans Syndrome1
Chronic Disease1
Communicable Diseases1
DNA Virus Infections1
Digestive System Diseases1

Trials

Showing 1 to 25 of 26. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.